Systemic inflammatory disorders such as Acute Respiratory Distress Syndrome (ARDS), vasculitis, sepsis, and acute cytokine release syndrome (CRS) induced by CAR-T therapies are associated with increased plasma levels of inflammatory stimuli such as cytokines TNFα and IFNγ.1 This evidence concerns the gene IFNG and congenital rubella syndrome.